Southport Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-10,000
Closed -$678K 42
2017
Q3
$678K Buy
+10,000
New +$632K 1.8% 22
2017
Q1
Sell
-7,500
Closed -$410K 27
2016
Q4
$410K Buy
+7,500
New +$426K 0.55% 41

Other funds holding AZN

Southport Management's AZN Position: Q4 2017 in Review

Southport Management sold out of AstraZeneca (AZN) in Q4 2017, closing a stake of 10,000 shares — an estimated $678K sold.

Southport Management first reported a position in AZN in Q4 2016 and held it in 2 quarters. The position peaked at $678K in Q3 2017. 503 funds tracked by Wall St. Rank hold AZN as of Q4 2017.

  • Southport Management reported no remaining AstraZeneca position as of Q4 2017 after selling out during the quarter.
  • Southport Management sold 10,000 AstraZeneca shares in Q4 2017, an estimated $678K.
  • Southport Management first reported a position in AstraZeneca in Q4 2016 and held it in 2 quarters.
  • Southport Management's AstraZeneca position peaked at $678K in Q3 2017.
  • 503 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2017.

Based on Southport Management's 13F filing for Q4 2017, filed 14 Feb 2018.